Homart
Privately held Australian pharmaceutical company founded in 1992, manufacturing health supplements, skincare, dairy, and pet nutrition products across 17 brands, distributed through 1,000+ Australian stores and international e-commerce platforms. Scheduled for May 2026 ASX listing.
- Company typePrivate
- Founded1992
- HeadquartersRydalmere, Australia
- Headcount51–100
- GTM typeB2C
- OfferingHardware or Manufacturing
What Homart does
Homart Pharmaceuticals Pty Ltd is a privately held Australian manufacturer and brand owner of health supplements, skincare, dairy, and pet nutrition products, founded in 1992 and headquartered in Rydalmere, NSW. The company controls a portfolio of 17 brands spanning everyday lifestyle through premium luxury positioning, including heritage assets Thompson's (75-year history, acquired 2024), Thursday Plantation (50-year history, acquired 2024), SpringLeaf, PETMIMA, Cheri, GrandPawPaw, Autili, and Salt Lab (magnesium wellness, acquired February 2026). Its self-owned facility is licensed by Australia's Therapeutic Goods Administration (TGA) under cGMP and holds ISO, FDA, and Halal certifications, supporting both proprietary branded production and OEM contract manufacturing for other brands.
The company operates a multi-channel go-to-market combining physical retail distribution across more than 1,000 Australian stores (Costco, Priceline, Chemist Warehouse, and independent pharmacies) with global e-commerce presence across Amazon Australia, eBay, Tmall, JD.com, VIP.com, Pinduoduo, and its own direct-to-consumer website. International expansion is concentrated on China through flagship enterprise partnerships with JD Health (flagship store operations, product incubation, anti-counterfeiting traceability), AliExpress (cross-border e-commerce targeting AUD 30 million in cumulative sales), and Tongrentang (premium pharmacy distribution for PETMIMA pet nutrition), as well as Southeast Asia via Central Group. PETMIMA holds 8 official China import approvals and SpringLeaf holds 5 NMPA overseas Blue Hat approvals, with 16 additional products in application for Hainan Free Trade Port entry via the Lecheng Pilot Zone.
The business model is primarily transactional product sales across four streams (health supplements, skincare, dairy, pet nutrition) supplemented by OEM contract manufacturing services. Revenue, funding history, and headcount detail beyond the 51-100 employee range are not publicly disclosed. The company has been bootstrapped and founder-controlled since inception by CEO Lynn Yeh, executing a brand acquisition strategy through 2024-2026 ahead of a scheduled May 2026 ASX listing that will introduce public shareholders and institutional capital.
Homart firmographics
Firmographics- Name
- Homart
- Legal name
- Homart Pharmaceuticals Pty Ltd
- Website
- https://homart.com.au
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Privately held Australian pharmaceutical company founded in 1992, manufacturing health supplements, skincare, dairy, and pet nutrition products across 17 brands, distributed through 1,000+ Australian stores and international e-commerce platforms. Scheduled for May 2026 ASX listing.
- Ownership category
- akta.pro rank
Homart industry classification
Industry- Product category
- Health Supplements
- NAICS
- Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151)
- SIC
- Dairy Products (2020)
- akta.pro primary industry
- Yogurt & Cultured Dairy Products Manufacturing (Kefir, Sour Cream, Labneh) (AFAKAKAC)
- akta.pro secondary industry
- Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt) (AFAKAKAH)
Keywords
Where Homart is headquartered
LocationHeadquarters
- HQ city
- Rydalmere
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Homart business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure
Revenue model
- Health Supplements Sales: Sale of nutritional supplements including vitamins, minerals, squalene products, fish oil, propolis, royal jelly, and specialty ingredients. Products sold under multiple brands including SpringLeaf, Thompson's, Health N Nature, and others. Distribution through pharmacy, retail, and e-commerce channels.
- Skincare Products Sales: Sale of skincare products including lanolin creams, pawpaw ointments, and beauty formulations. Brands include Cheri, GrandPawPaw, and TopLife skincare lines. Available through pharmacy, retail, and e-commerce channels.
- Dairy Products Sales: Functional dairy products including colostrum milk powder, lactoferrin products, and milk powders under the Autili brand. Includes specialized formulations like HMO-enhanced products.
- Pet Nutrition Sales: Pet supplement sales through PETMIMA brand including imported products to China market. Brand has received 8 official import approvals from China's Ministry of Agriculture.
- OEM Contract Manufacturing: Contract manufacturing services for health supplements, beauty and skincare, and dairy products for mother and baby. Services offered to other brands seeking Australian manufacturing.
Go-to-market motion3 records
Distribution channels14 records
Marketing channels8 records
Homart product offering
Product offeringCore offering
Homart manufactures and distributes Australian-made health supplements, skincare, and functional dairy products across a portfolio of 17 owned brands including SpringLeaf, Thompson's, Thursday Plantation, TopLife, and PETMIMA. The company also operates an OEM contract manufacturing service producing health supplements, beauty/skincare, and mother-and-baby dairy products for third-party brands at its TGA-licensed Rydalmere facility.
Differentiator
Problem solved
Functional benefit
Brands
- SpringLeaf: Health supplement brand including SpringLeaf Classic, SpringLeaf Premium (SLC), and Spring Leaf II product lines
- Thompson's
- Thursday Plantation
- TopLife
- Health N Nature
- Golden Hive
- Cheri
- GrandPawPaw
- Autili
- Vita Best
- Urvita
- Salt Lab
- PETMIMA
- Little Innoscents
Products and services
- SpringLeaf Health Supplements
Quantifiable outcome
- 8 official import approvals from China's Ministry of Agriculture for PETMIMA brand
- +2 more outcomes
Companies that use Homart
Customer profileNamed customers12 records
Segments6 records
Ideal customer profiles6 records
Homart technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Homart partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered flagship and core.
- Salt LabflagshipAcquisition completed of Australian magnesium wellness brand specializing in sleep and muscle discomfort products. Salt Lab is known for minimalist, clean, and verifiable formulations with strong online presence in Australia and New Zealand, including Amazon and Nordstrom distribution. Acquisition follows Homart's 2024 acquisitions of Thompson's (75-year-old brand) and Thursday Plantation (50-year-old brand).
- JD HealthflagshipStrategic cooperation agreement signed during CIIE 2025, focusing on flagship store operations, new product incubation, consumer education, and anti-counterfeiting traceability. Partnership witnessed by Australian Minister for Trade and Tourism Hon Don Farrell and Austrade CEO Dr Paul Grimes. Aims to strengthen brand building and service upgrades for Australian health products in China.
- AliExpresscoreStrategic MOU signed for cross-border e-commerce, global marketing, and digital retail collaboration. Initial rollout featuring SpringLeaf, TopLife, GrandPawPaw, and Cheri brands with about 40 SKUs, expanding to 200 SKUs within three years. Target cumulative sales of AUD 30 million. Ceremony attended by CEO Lynn Yeh and Austrade representatives.
- AustradecoreAustralian Trade and Investment Commission providing support for international expansion partnerships including CIIE participation and partnerships with JD Health and AliExpress. CEO Dr Paul Grimes witnessed key partnership signings.
- Australian MadecoreAustralian Made campaign supporting international brand presence. CEO Ben Lazzaro attended AliExpress MOU signing ceremony at CIIE 2025.
- Central GroupcorePartnership strengthened at Vitafoods Asia 2025 in Bangkok. Homart conducted comprehensive product training sessions for Central Group's sales and marketing teams to enhance understanding of product portfolio and brand values. Collaboration laying foundation for expanding presence in Thailand and broader Southeast Asian market.
- TongrentangcoreStrategic cooperation agreement signed at Asia Pet Fair 2025. PETMIMA products will enter Tongrentang flagship and franchise stores across China leveraging their strong brand reputation and nationwide network. Ceremony witnessed by Stephanie, Commercial Consul of Austrade.
- Shanghai Huanshi Supply Chain Management Co., Ltd.coreStrategic cooperation agreement signed at Asia Pet Fair 2025 for PETMIMA brand distribution in China. Partnership witnessed by Stephanie, Commercial Consul of Austrade.
Scale indicators9 records
Recent moves7 records
Expansion highlights8 records
Homart competitors and assessment
Company assessmentDirect peers
- Blackmores Limited: Australia's largest publicly-listed health supplement company (ASX: BKL), offering vitamins, minerals, herbal, and nutritional supplements. Closely comparable to Homart in product mix, Australian manufacturing, and Asia-Pacific distribution focus, but with substantially larger scale and brand recognition.
- Swisse Wellness: Australian premium health and wellness brand owned by Health & Happiness International. Directly comparable to Homart's SpringLeaf and Thompson's premium supplement lines, with strong presence in Australian pharmacy channel and significant Chinese cross-border e-commerce exposure.
- Nature's Own (Sanofi Consumer Healthcare): One of Australia's most recognized supplement brands, owned by Sanofi Consumer Healthcare. Directly comparable to Homart's SpringLeaf in mainstream Australian pharmacy supplement positioning, channel strategy, and consumer brand recognition.
- Herbs of Gold: Australian-owned supplement company specializing in herbal and nutritional supplements. Closely comparable to Homart in product range, Australian manufacturing focus, and pharmacy/health food retail channel strategy at similar mid-market scale.
- Metagenics Australia: Australian nutritional medicine company offering practitioner-grade supplements. Comparable to Homart in TGA-licensed manufacturing and health professional channel focus, though more concentrated in practitioner-only distribution.
- Bioglan (PharmaCare Laboratories): Australian health supplement brand owned by PharmaCare Laboratories, offering vitamins, minerals, and natural health products. Closely comparable to Homart in Australian pharmacy channel presence, product portfolio breadth, and mid-market positioning.
- Vitaco Holdings: Trans-Tasman health and wellness company (Musashi, Aussie Bodies) with Australian and New Zealand manufacturing. Comparable product mix in supplements and functional nutrition, with similar retail pharmacy distribution and export focus.
Broad incumbents
- Sanofi Consumer Healthcare (Australia): Global pharmaceutical major's consumer health division operating in Australia with brands like Nature's Own and Cenovis. Comparable to Homart in Australian pharmacy distribution and supplement categories, but operating as part of a much larger multinational portfolio.
- Bayer Consumer Health (Australia): Global healthcare major with Australian consumer health operations including Elevit, Berocca, and other supplement brands. Comparable distribution footprint in Australian pharmacies but broader global scale and category reach than Homart.
- Health & Happiness International: Hong Kong-listed parent of Swisse Wellness with diversified health and wellness portfolio. Comparable to Homart in Australian health supplement manufacturing and Chinese cross-border e-commerce focus, but with substantially larger scale and broader category reach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Homart social profiles
Digital presenceHomart financial estimates
Financial estimateRevenue estimate
Valuation estimate
Homart leadership team
Management profileNumber of profiles
Profiles1 record
Homart subsidiaries and ownership
Company hierarchySubsidiaries3 records
Homart funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Homart M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Homart
What does Homart do?
Homart manufactures and distributes Australian-made health supplements, skincare, and functional dairy products across a portfolio of 17 owned brands including SpringLeaf, Thompson's, Thursday Plantation, TopLife, and PETMIMA. The company also operates an OEM contract manufacturing service producing health supplements, beauty/skincare, and mother-and-baby dairy products for third-party brands at its TGA-licensed Rydalmere facility.
Is Homart a public or private company?
Homart is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Homart founded?
Homart was founded in 1992. It employs 51 to 100 people.
Where is Homart based?
Homart is headquartered in Rydalmere, Australia, in the Oceania region.
How does Homart make money?
Five revenue lines are on record. Health Supplements Sales are the primary driver. The others are skincare Products Sales, dairy Products Sales, pet Nutrition Sales and OEM Contract Manufacturing.
Who are Homart's main competitors?
Direct peers on record are Blackmores Limited, Swisse Wellness, Nature's Own (Sanofi Consumer Healthcare), Herbs of Gold, Metagenics Australia, Bioglan (PharmaCare Laboratories) and Vitaco Holdings. Broad incumbents are Sanofi Consumer Healthcare (Australia), Bayer Consumer Health (Australia) and Health & Happiness International.
Does Homart have an API?
No public API is recorded for Homart.
What industry is Homart in?
Homart's product category is Health Supplements. Its primary akta.pro industry code is AFAKAKAC, Yogurt & Cultured Dairy Products Manufacturing (Kefir, Sour Cream, Labneh), with a secondary code of AFAKAKAH, Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt). Its NAICS code is 3115 and its SIC code is 2020.